A bladder scan is a safe, painless, reliable procedure that allows doctor to assess the volume of urine retained within the bladder. The bladder scan measures ultrasonic reflections within the body to differentiate the urinary bladder from the surrounding tissue. A bladder scanner is a non-invasive tool used to diagnose, manage, and treat urinary outflow dysfunction. The bladder scanner can be used to help identify bladder distention, identify causes of urinary frequency and bladder irritability. There are several additional benefits to using a bladder scanner as a diagnostic tool. Bladder scanner may also be useful in assisting with accurate assessment of a patient's hydration status. Bladder scanners are the safest option for healthcare providers to use for patients experiencing urine retention.

Market Statistics:

The global bladder scanners market is estimated to account for US$ 141.3 Mn in terms of value by the end of 2022.


Increasing prevalence of urology related disorders is expected to augment the growth of the global bladder scanners market during the forecast period. Chronic kidney disease (CKD) is a state of chronic inflammation. Chronic inflammation weakens the body's immune response to infections. Hence, CKD patients are at an increased risk of infections. Thus, with the increase in prevalence of urology related disorders, the use of bladder scanners is also increasing with a rapid pace. According to the U.S. Centers for Disease Control and Prevention (CDC), kidney diseases are a leading cause of death in the United States. More than 37 million US adults are estimated to have CKD, and most are undiagnosed.


Increasing use of portable or handheld bladder scanners around the world is expected to offer significant growth opportunities for players in the global bladder scanners market. There has been a significant development in portable or handheld bladder scanner devices which provides further guidance for the treatment. Thus, there is an increasing demand for portable or handheld bladder scanners. In February 2022, Fujifilm announced the launch of iVizHandheld system. This system is capable of performing bladder volume scanning.


Product recalls and stringent regulatory reforms are some major factors expected to hamper the growth of the global bladder scanners market. In the U.S., medical devices are regulated by the Food and Drug Administration (FDA) to ensure safety and effectiveness of the devices. In the United States, most Class I devices are exempt from Premarket Notification 510(k), most Class II devices require Premarket Notification 510(k), and most Class III devices require Premarket Approval.  While, a product recall is request to return to the maker, a batch or entire production run of a product, usually over safety concerns or design defects or labelling errors.

Global Bladder Scanners Market - Impact of Coronavirus (Covid-19) Pandemic

COVID-19 was announced as a pandemic by the World Health Organization (WHO) on March 11, 2020, and this unprecedented health event places massive pressure on health care systems worldwide. The pandemic also had a severe impact on the bladder scanner market, as various public health organizations have issued guidelines for the diagnosis of bladder cancer during the pandemic. Such postponing the scanning methods has impacted the growth of the market. However, it is also known as COVID-19–associated Cystitis (CAC), which includes increased pain, nocturia, frequency, and urinary urgency. Such new symptoms associated with COVID-19 are expected to aid in the growth of the market.

To know the latest trends and insights prevalent in this market, click the link below:


Key Takeaways:

The global bladder scanners market was valued at US$ 134.1 Mn in 2021 and is forecast to reach a value of US$ 194.3 Mn by 2028 at a CAGR of 5.4% between 2022 and 2028.

Among product portable bladder scanners segment held dominant position in the global bladder scanners market in 2021, accounting for 53.5% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.

Market Trends:

  1. Increasing prevalence of bladder cancer worldwide is expected to propel growth of the global bladder scanners market. For instance, in March 2021, Lingen Davies Cancer Fund funded a new bladder scanner for the radiotherapy department at Royal Shrewsbury Hospital, allowing patients with bladder, gynecological, prostate, and/or colorectal tumors to access this enhanced scanning equipment.
  2. Technological advancements in bladder scanners is expected to propel growth of the global bladder scanners market. For instance, in June 2022, Paige and Janssen collaborated to evaluate the potential of a hematoxylin and eosin (H&E)-based, AI-powered biomarker test to predict the presence of bladder cancer.

Competitive Landscape:

Major players operating in the global bladder scanners market include Vitacon, SRS Medical Systems Inc., Roper Technologies Inc., Patricia Industries (LABORIE), Echo-Son SA, Mcube Technology Co. Ltd., Caresono, General Electric Company (GE Healthcare Inc.), and Becton, Dickinson and Company (C. R. Bard Inc.), among others.

Recent Developments:

In October 2021, Laborie acquired Pelvalon, a medical technology company that has developed the Eclipse System, an innovative, non-surgical, patient-controlled device for women suffering from fecal incontinence.

In September 2020, Roper Technologies Inc. completed its previously announced acquisition of Vertafore, a leading modern insurance technology company, which built and supported superior Insurtech solutions to connect every point of the distribution channel.


Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo